Iterum Therapeutics plc

Ownership Transactions Reported by 9 Insiders

Symbol
ITRM on Nasdaq
Location
Fitzwilliam Court, 1 St Floor, Leeson Close, Dublin 2, Ireland

Insiders trading volume in the past year

Iterum Therapeutics plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ronald Hunt Director $483K Aug 6, 2024
Michael W. Dunne Director $308K Aug 6, 2024
Corey N. Fishman Chief Executive Officer, Director $192K Aug 6, 2024
Beth Hecht Director $26.4K Jun 15, 2023
Mark Chin Director $25.6K Jun 15, 2023
Sailaja Puttagunta Chief Medical Officer $14.5K Dec 1, 2023
Judith M. Matthews Chief Financial Officer Mar 31, 2023
David G. Kelly Director Jun 15, 2022
Brenton K. Ahrens Director Dec 23, 2022

Recent Insider Transactions by Companies or Individuals for Iterum Therapeutics plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.